top
Search terms
Results 1 - 10 of 28 - ordered by :
Pages: 1 2 3
Escardio

From 12th to 14th June 2019, The ESC Working Group of Thrombosis and ESC Working Group on Aorta & Peripheral Artery Disease got together to deliver a residential course focused on providing an update ...

Date : 12/07/2019
ESC365

Long term risk and costs of bleeding in men and women treated with triple antithrombotic therapy.

Date : 02/09/2019
ESC365

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Conclusion.

Date : 04/03/2019
ESC365

Balancing antithrombotic therapy in atrial fibrillation patients undergoing cardiovascular interventions: update on clinical evidence and guideline recommendations.

Date : 03/03/2019
ESC365

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - CONTRA

Date : 04/03/2019
ESC365

Changes in antithrombotic therapy after atrial fibrillation diagnosis

Date : 31/08/2019
ESC365

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Moderated discussion.

Date : 04/03/2019
ESC365

De-escalation of the antithrombotic therapy is independently associated with low risk of total mortality in patients with acute coronary syndrome (ACS) in real practice

Date : 04/03/2019
ESC365

Positioning of the topic - DAT for all ACS patients with atrial fibrillation receiving coronary stents

Date : 04/03/2019
ESC365

Triple vs. double antithrombotic therapy in patients needing oral anticoagulation undergoing percutaneous coronary intervention: a meta-analysis

Date : 01/09/2019